文献速递耳科与耳神经

阿尔茨海默病相关分析物β-淀粉样蛋白与tau在外淋巴液中的检测:与患者年龄及认知评分的相关性

Alzheimer's Disease-Related Analytes Amyloid-β and Tau in Perilymph: Correlation With Patient Age and Cognitive Score.
PubMed 文献 · Otolaryngol Head Neck Surg · 2024-08-27

前瞻性研究纳入25例人工耳蜗植入患者,用聚酰亚胺管采集外淋巴液并以单分子阵列数字酶联免疫吸附平台检测Aβ40、Aβ42和总tau。三种分析物均可在人外淋巴液中检出,浓度约比脑脊液低10倍,且随年龄升高并与认知评分相关。

要点

  • 外淋巴液体积约1至13微升,分析物浓度范围2.67至1088.26皮克/毫升。
  • Aβ42、Aβ40和总tau水平与年龄呈正相关,MoCA评分与年龄呈负相关。
  • 总tau及Aβ42/Aβ40比值与MoCA评分显著相关,提示或可作为认知障碍生物标志物。

核心结论

  • 阿尔茨海默病相关肽Aβ42、Aβ40和tau分析物可在人外淋巴液中检出,水平约比脑脊液低10倍。
  • 这些分析物随年龄增加并与认知障碍指标相关,提示其或可作为接受人工耳蜗植入患者认知障碍的生物标志物。
  • 未来研究应探讨这些分析物在外淋巴液中的来源及其与内耳病变和听力损失的潜在联系,以及其与个体脑脊液和血浆水平的关系。

研究设计与样本

  • 前瞻性研究,纳入25例患者,于人工耳蜗植入术中采集外淋巴液。
  • 使用聚酰亚胺管采集以避免淀粉样蛋白黏附于玻璃,并以单分子阵列先进数字酶联免疫吸附平台检测Aβ40、Aβ42和总tau。
  • 认知功能采用蒙特利尔认知评估(MoCA)评估。
  • 研究场所为三级转诊中心。

主要发现

  • 外淋巴液体积范围约1至13微升,分析物浓度跨度2.67至1088.26皮克/毫升。
  • 所有样本均可检出总tau、Aβ40和Aβ42,Aβ42与Aβ40水平呈显著正相关。
  • Aβ42、Aβ40和总tau水平与年龄呈正相关,MoCA评分与年龄呈负相关。
  • 总tau和Aβ42/Aβ40比值与MoCA评分显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the collection methods for perilymph fluid biopsy during cochlear implantation, detect levels of amyloid β 42 and 40 (Aβ42 and Aβ40), and total tau (tTau) analytes with a high-precision assay, to compare these levels with patient age and Montreal Cognitive Assessment (MoCA) scores, and explore potential mechanisms and relationships with otic pathology. STUDY DESIGN: Prospective study. SETTING: Tertiary referral center. METHODS: Perilymph was collected from 25 patients using polyimide tubing to avoid amyloid adherence to glass, and analyzed with a single-molecule array advanced digital enzyme-linked immunosorbent assay platform for Aβ40, Aβ42, and tTau. Cognition was assessed by MoCA. RESULTS: Perilymph volumes ranged from ∼1 to 13 µL, with analyte concentrations spanning 2.67 to 1088.26 pg/mL. All samples had detectable levels of tTau, Aβ40, and Aβ42, with a significant positive correlation between Aβ42 and Aβ40 levels. Levels of Aβ42, Aβ40, and tTau were positively correlated with age, while MoCA scores were inversely correlated with age. tTau and Aβ42/Aβ40-ratios were significantly correlated with MoCA scores. CONCLUSION: Alzheimer's disease-associated peptides Aβ42, Aβ40, and tau analytes are detectable in human perilymph at levels approximately 10-fold lower than those found in cerebrospinal fluid (CSF). These species increase with age and correlate with cognitive impairment indicators, suggesting their potential utility as biomarkers for cognitive impairment in patients undergoing cochlear implantation. Future research should investigate the origin of these analytes in the perilymph and their potential links to inner ear pathologies and hearing loss, as well as their relationships to CSF and plasma levels in individuals.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Walia A, Shew MA, Durakovic N, et al. Alzheimer's Disease-Related Analytes Amyloid-β and Tau in Perilymph: Correlation With Patient Age and Cognitive Score. Otolaryngol Head Neck Surg. 2024. PMID: 39189154. doi:10.1002/ohn.942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。